{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T09:51:53Z","timestamp":1676541113829},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s13312-012-0028-2","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T07:31:48Z","timestamp":1332487908000},"page":"139-143","source":"Crossref","is-referenced-by-count":9,"title":["Retinopathy of prematurity\u2014promising newer modalities of treatment"],"prefix":"10.1007","volume":"49","author":[{"given":"H. S.","family":"Niranjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Benakappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. R. Bharath Kumar","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Shivananda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Vasudeva","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"28_CR1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-3016.2003.00545.x","volume":"18","author":"T.I. Kim","year":"2004","unstructured":"Kim TI, Sohn J, Pi SY, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol. 2004;18:130\u2013134.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"28_CR2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/0301-4738.33817","volume":"55","author":"A. Vinekar","year":"2007","unstructured":"Vinekar A, Dogra MR, Sangtam T, Narang A, Gupta A. Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: ten year data from a tertiary care centre in a developing country. Indian J Ophthalmol. 2007;55:331\u2013336.","journal-title":"Indian J Ophthalmol"},{"key":"28_CR3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0002-9394(86)90397-1","volume":"102","author":"L.P. Chong","year":"1986","unstructured":"Chong LP, Machemer R, de Juan E Jr. Vitrectomy for advanced stage of ROP. Am J Ophthalmol. 1986;102:710\u2013716.","journal-title":"Am J Ophthalmol"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","volume":"106","author":"Cryotherapy for retinopathy of prematurity cooperative group.","year":"1988","unstructured":"Cryotherapy for retinopathy of prematurity cooperative group. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Arch Ophthalmol. 1988;106:471\u2013479.","journal-title":"Arch Ophthalmol"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archopht.1990.01070120056029","volume":"108","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group.","year":"1990","unstructured":"Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial for cryotherapy for retinopathy of prematurity: one-year outcome-structure and function. Arch Ophthalmol. 1990;108:1408\u20131416.","journal-title":"Arch Ophthalmol"},{"key":"28_CR6","first-page":"154","volume":"1122","author":"Laser ROP Study Group.","year":"1994","unstructured":"Laser ROP Study Group. Laser therapy for retinopathy of prematurity. Arch Ophthalmol. 1994;112 2:154\u2013156.","journal-title":"Arch Ophthalmol"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/adc.63.10_Spec_No.1151","volume":"63","author":"F.L. Kretzer","year":"1988","unstructured":"Kretzer FL, Hittner HM. Retinopathy of prematurity: clinical implications of retinal development. Arch Dis Child. 1988;63:1151\u20131167.","journal-title":"Arch Dis Child"},{"key":"28_CR8","first-page":"359","volume":"100","author":"N. Ashton","year":"1980","unstructured":"Ashton N. Oxygen and the retinal blood vessels. Trans Ophthalmol Soc UK. 1980;100:359\u2013362.","journal-title":"Trans Ophthalmol Soc UK"},{"key":"28_CR9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2741\/1847","volume":"11","author":"K. Csak","year":"2006","unstructured":"Csak K, Szabo V, Szabo A, Vannay A. Pathogenesis and genetic basis for retinopathy of prematurity. Front Biosci. 2006;11:908\u2013920.","journal-title":"Front Biosci"},{"key":"28_CR10","first-page":"1029","volume":"146","author":"H.F. Dvorak","year":"1995","unstructured":"Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029\u20131039.","journal-title":"Am J Pathol"},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","volume":"13","author":"G. Neufeld","year":"1999","unstructured":"Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9\u201322.","journal-title":"FASEB J"},{"key":"28_CR12","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","volume":"15","author":"J. Stone","year":"1995","unstructured":"Stone J, Itin A, Alon T, Pe\u2019er J, Gnessin H, Chan-Ling T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738\u20134747.","journal-title":"J Neurosci"},{"key":"28_CR13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/376062a0","volume":"376","author":"F. Shalaby","year":"1995","unstructured":"Shalaby F, Rossant J, Yamaguchi TP, Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376:62\u201366.","journal-title":"Nature"},{"key":"28_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00246-002-0266-5","volume":"24","author":"W. Himeno","year":"2003","unstructured":"Himeno W, Akagi T, Furui J. Increased angiogenic growth factor in cyanotic congenital heart disease. Pediatr Cardiol. 2003;24:127\u2013132.","journal-title":"Pediatr Cardiol"},{"key":"28_CR15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1164\/ajrccm.159.5.9806073","volume":"159","author":"P. Lassus","year":"1999","unstructured":"Lassus P, Ristimaki A, Ylikorkala O, Viinikka L, Andersson S. Vascular endothelial growth factor in human preterm lung. Am J Respir Crit Care Med. 1999;159:1429\u20131433.","journal-title":"Am J Respir Crit Care Med"},{"key":"28_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/mvre.1998.2111","volume":"56","author":"K. Suzuma","year":"1998","unstructured":"Suzuma K, Takagi H, Otani A, Suzuma I, Honda Y. Increased expression of KDR\/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization. Microvasc Res. 1998;56:183\u2013191.","journal-title":"Microvasc Res"},{"key":"28_CR17","first-page":"474","volume":"43","author":"D.S. McLeod","year":"2002","unstructured":"McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA. Localization of VEGF receptor-2 (KDR\/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2002;43:474\u2013482.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"28_CR18","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)65004-3","volume":"156","author":"K. Lashkari","year":"2000","unstructured":"Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol. 2000;156:1337\u20131344.","journal-title":"Am J Pathol"},{"key":"28_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000071173","volume":"35","author":"N. Umeda","year":"2003","unstructured":"Umeda N, Ozaki H, Hayashi H. Colocalization of Tie2, angiopoietin 2 and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity. Ophthalm Res. 2003;35:217\u2013223.","journal-title":"Ophthalm Res"},{"key":"28_CR20","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.ghir.2004.03.030","volume":"14","author":"L.E. Smith","year":"2004","unstructured":"Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res. 2004;14:S140\u2013S144.","journal-title":"Growth Horm IGF Res"},{"key":"28_CR21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"R.L. Avery","year":"2006","unstructured":"Avery RL, Pieramici DJ, Rabena MD. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113:363\u2013372.","journal-title":"Ophthalmology"},{"key":"28_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","volume":"113","author":"R.L. Avery","year":"2006","unstructured":"Avery RL, Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, et al. Intravitreal bevacizumab (Avastin) for neovascular agerelated macular degeneration. Ophthalmology. 2006;113:363\u2013372.","journal-title":"Ophthalmology"},{"key":"28_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajo.2006.02.015","volume":"142","author":"Y. Oshima","year":"2006","unstructured":"Oshima Y, Sakaguchi H, Gomi F, Tano Y. Regression of iris neovasculariztion after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol. 2006;142:155\u2013158.","journal-title":"Am J Ophthalmol"},{"key":"28_CR24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","volume":"92","author":"S. Kusaka","year":"2008","unstructured":"Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol. 2008;92:1450\u20131455.","journal-title":"Br J Ophthalmol"},{"key":"28_CR25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","volume":"28","author":"H. Mintz-Hittner","year":"2008","unstructured":"Mintz-Hittner H, Kuffel R. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina. 2008;28:831\u2013838.","journal-title":"Retina"},{"key":"28_CR26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","volume":"90","author":"A.E. Fung","year":"2006","unstructured":"Fung AE, Rosenfeld PJ, Reichel E. The international intravitreal bevacizumab safety survey: Using the internet to assess drug safety worldwide. Br J Ophthalmol. 2006;90:1344\u20131349.","journal-title":"Br J Ophthalmol"},{"key":"28_CR27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/0301-4738.36502","volume":"55","author":"T. Velpandian","year":"2007","unstructured":"Velpandian T, Sharma C, Garg SP, Mandal S, Ghose S. Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries. Indian J Ophthalmol. 2007;55:488\u2013490.","journal-title":"Indian J Ophthalmol"},{"key":"28_CR28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bjo.2008.156208","volume":"93","author":"B.A. Darlow","year":"2009","unstructured":"Darlow BA, Gilbert C, Quinn GE. Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity. Br J Ophthalmol. 2009;93:986.","journal-title":"Br J Ophthalmol"},{"key":"28_CR29","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","volume":"98","author":"A. Hellstrom","year":"2001","unstructured":"Hellstrom A, Perruzzi C, Ju M, Engstrom E, H\u00e5rd AL, Liu J, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity. PNAS. 2001;98:5804\u20135808.","journal-title":"PNAS"},{"key":"28_CR30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","volume":"112","author":"A. Hellstrom","year":"2003","unstructured":"Hellstrom A, Engstrom E, Hard AL, Albertsson-Wikland K, Carlsson B, Niklasson A, et al. Postnatal serum insulinlike growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003;112:1016\u20131020.","journal-title":"Pediatrics"},{"key":"28_CR31","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","volume":"98","author":"A. Hellstrom","year":"2001","unstructured":"Hellstrom A, Perruzzi C, Ju M, Engstrom E, Sjodell L, Liu J, et al. Low IGF-I suppresses VEGF survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci USA. 2001;98:5804\u20135808.","journal-title":"Proc Natl Acad Sci USA"},{"key":"28_CR32","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1210\/jc.87.7.3413","volume":"87","author":"A. Hellstrom","year":"2002","unstructured":"Hellstrom A, Carlsson B, Niklasson A, Segestam K, Boguszewski M, Laron Z, et al. IGFI \u2014 is critical for normal vascularization of the human retina; J Clin Endocrinol Metabo. 2002;87:3413\u20133416.","journal-title":"J Clin Endocrinol Metabo"},{"key":"28_CR33","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1203\/PDR.0b013e31819d9e8c","volume":"65","author":"C. L\u00f6fqvist","year":"2009","unstructured":"L\u00f6fqvist C, Niklasson A, Engstr\u00f6m E, Friberg LE, Camacho-H\u00fcbner C, Ley D, et al. A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infants; Pediatr Res. 2009;65:574\u2013579.","journal-title":"Pediatr Res"},{"key":"28_CR34","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2010-05-286963","volume":"117","author":"H. Kojima","year":"2011","unstructured":"Kojima H, Otani A, Oishi A, Makiyama Y, Nakagawa S, Yoshimura N. Granulocyte colony-stimulating factor attenuates oxidative stress-induced apoptosis in vascular endothelial cells and exhibits functional and morphologic protective effect in oxygen-induced retinopathy; Blood. 2011;117:1091\u20131100.","journal-title":"Blood"},{"key":"28_CR35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jaapos.2009.07.007","volume":"13","author":"R. Bhola","year":"2009","unstructured":"Bhola R, Purkiss T, Hunter S, Stewart D, Rychwalski PJ. Effect of granulocyte colony-stimulating factor on the incidence of threshold retinopathy of prematurity. J AAPOS. 2009;13:450\u2013453.","journal-title":"J AAPOS"},{"key":"28_CR36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/15216540500097111","volume":"57","author":"M. Karin","year":"2005","unstructured":"Karin M, Gallagher E. From JNK to pay dirt: Jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life. 2005:57:283\u2013295.","journal-title":"IUBMB Life"},{"key":"28_CR37","doi-asserted-by":"crossref","first-page":"26484","DOI":"10.1074\/jbc.M002104200","volume":"275","author":"G. Pages","year":"2000","unstructured":"Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J. Stress-activated protein kinases (JNK and p38\/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem. 2000;275:26484\u201326491.","journal-title":"J Biol Chem"},{"key":"28_CR38","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1073\/pnas.0902659106","volume":"106","author":"M. Guma","year":"2009","unstructured":"Guma M, Rius J, Karen X. Duong-Polk, Haddad GG, Lindsey JD, et al. Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression. PNAS. 2009;106;8760\u20138765.","journal-title":"PNAS"},{"key":"28_CR39","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1073\/pnas.0902659106","volume":"106","author":"M. Guma","year":"2009","unstructured":"Guma M, Rius J, Duong-Polk KX, Haddad GG, Lindsey JD, Karin M. Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression. Proc Natl Acad Sci USA. 2009;106:8760\u20138765.","journal-title":"Proc Natl Acad Sci USA"},{"key":"28_CR40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1586\/17469899.2.2.275","volume":"2","author":"P. Kwinta","year":"2007","unstructured":"Kwinta P, Pietrzyk JJ. Retinopathy of prematurity: is genetic predisposition an important risk factor? Exp Rev Ophthalmol. 2007;2:275\u2013283.","journal-title":"Exp Rev Ophthalmol"},{"key":"28_CR41","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/bjo.2007.117283","volume":"91","author":"G. Holmstr\u00f6m","year":"2007","unstructured":"Holmstr\u00f6m G, van Wijngaarden P, Coster DJ, Williams KA. Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. Br J Ophthalmol. 2007;91:1704\u20131708.","journal-title":"Br J Ophthalmol"},{"key":"28_CR42","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1038\/sj.gt.3302366","volume":"11","author":"F. Rolling","year":"2004","unstructured":"Rolling F. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. Gene Therapy. 2004;11:S26\u2013S22.","journal-title":"Gene Therapy"},{"key":"28_CR43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bjo.85.8.891","volume":"85","author":"S. Chower","year":"2001","unstructured":"Chower S. Gene therapy for retinopathy of prematurity: the eye is a window to the future. Br J Ophthalmol. 2001;85:891\u2013893.","journal-title":"Br J Ophthalmol"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-012-0028-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13312-012-0028-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-012-0028-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:04:12Z","timestamp":1561507452000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13312-012-0028-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s13312-012-0028-2","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}